Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 1

1(25.0%)

Phase 4

1(25.0%)

4Total

N/A(2)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06782152Not Yet Recruiting

AVEIR™ Leadless Pacemaker Registry in Europe and MIddle East Region (PREMIER LEADLESS)

Role: lead

NCT06545305Enrolling By Invitation

Incidence and Risk Factors of Ocular Complications Among Patients With Homocystinuria

Role: lead

NCT05242796Not ApplicableCompleted

Effects of Low Frequency Magnet Therapy on Spasticity in Patients With Cerebral Palsy

Role: lead

NCT03388437Not ApplicableCompleted

Non-invasive Neurally Adjusted Ventilatory Assist Versus Nasal Intermittent Positive Pressure Ventilation for Preterm Infants After Extubation

Role: lead

NCT01823185Phase 4Unknown

Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy

Role: collaborator

NCT01243866Phase 1Completed

Effect of Dental Treatment on Children's Growth

Role: lead

All 6 trials loaded